Albuterol Sulfate Solution Shortage: Latest Updates and Availability
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has listed Albuterol Sulfate Solution as a current shortage, affecting medications used in pediatric and pulmonary care.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Albuterol Sulfate.
What's in Shortage
Albuterol Sulfate Solution is currently listed as being in shortage. This medication, which includes the brand name ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%, is a solution used primarily in pediatric and pulmonary/allergy therapeutic categories.
Which Manufacturers Are Affected
The following manufacturer is listed in the database:
- Ritedose Pharmaceuticals, LLC: Status is currently Available.
- Presentation: Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)
- Contact: 803-806-3300
Why There's a Shortage
No specific reason for the shortage of Albuterol Sulfate Solution was provided in the current FDA report.
What Patients Should Do
Patients who depend on this medication for respiratory health should take the following steps:
- Consult your pharmacist to check the current stock levels at your local pharmacy.
- Contact the manufacturer (Ritedose Pharmaceuticals at 803-806-3300) if you have specific questions about supply.
- Speak with your healthcare provider to discuss your treatment plan and any concerns regarding availability.
Disclaimer: Patients should always consult their healthcare provider for medical advice and before making any changes to their medication regimen.
Source
Information provided by the FDA Drug Shortage Database. Initial posting date: 10/25/2022. Last updated: 03/02/2026.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.